CLIO Cosmetics Co.,Ltd (KOSDAQ:237880)

South Korea · Delayed Price · Currency is KRW

10,770

+260 (2.47%)

At close: Nov 10, 2026

Market Cap	188.74B -20.2%
Revenue (ttm)	329.59B -0.2%
Net Income	29.45B +121.9%
EPS	1,641.89 +125.7%
Shares Out	17.52M
PE Ratio	6.56
Forward PE	7.20
Dividend	250.00 (2.32%)
Ex-Dividend Date	Dec 29, 2025

Volume	50,483
Open	10,630
Previous Close	10,510
Day's Range	10,520 - 10,860
52-Week Range	8,800 - 14,800
Beta	0.40
Analysts	Buy
Price Target	14,350.00 (+33.24%)
Est. Earnings	Nov 17, 2026

About CLIO Cosmetics Co.,Ltd

CLIO Cosmetics Co.,Ltd engages in sales and distribution of cosmetics products and cosmetic tools in South Korea and internationally. It offers eye liner and brow, cushion, lipstick, lip tint, shading, cream, skincare mask, hair care products, as well as body and perfumes. The company offers its products under the CLIO, peripera, goodal, DERMATORY, TYPE NUMBER, TRUE RX, and Healing Bird brands through its CLUB CLIO shopping mall, as well as provides professional services through offline stores and online malls. CLIO Cosmetics Co.,Ltd was founde... [Read more]

Industry Perfumes, Cosmetics, and Other Toilet Preparations

Founded 1993

Employees 336

Stock Exchange KOSDAQ

Ticker Symbol 237880

Full Company Profile

Financial Performance

In 2025, CLIO Cosmetics Co.,Ltd's revenue was 328.90 billion, a decrease of -6.39% compared to the previous year's 351.37 billion. Earnings were 13.56 billion, a decrease of -51.33%.

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for 237880 stock is "Buy." The 12-month stock price target is ₩14,350, which is an increase of 33.24% from the latest price.

Price Target

₩14,350

(33.24% upside)

Analyst Consensus: Buy

Stock Forecasts